DENGUE VIRUS TYPE 1 NS1 ANTIGEN Recombinant Protein

RECOMBINANT DENGUE VIRUS TYPE 1 NS1 ANTIGEN

Cat. Num. AAA232530

• Applications: ELISA
• Purity: >95% by SDS PAGE analysis
• Synonyms: DENGUE VIRUS TYPE 1 NS1 ANTIGEN; RECOMBINANT DENGUE VIRUS TYPE 1 NS1 ANTIGEN; DENGUE VIRUS TYPE 1 NS1 ANTIGEN recombinant protein

• Purity/Purification: >95% by SDS PAGE analysis
• Form/Format: Purified recombinant protein with a C-terminal 6 x HIs-tag - liquid.
• Concentration: Approximate Protein Concentration: 0.5 mg/ml (varies by lot)

• Applicable Applications for DENGUE VIRUS TYPE 1 NS1 ANTIGEN recombinant protein: ELISA (EIA)
• Preparation: Recombinant dengue virus serotype 1 NS1 protein, sequence strain Nauru/Western Pacific/1974, expressed in 293 human cells
• Buffer Solution: Dulbecco's phosphate buffered saline
• Target Species: Viral
• Preservative Stabilizers: None present.
• Preparation and Storage: Store at room temperature (ambient) for up to 2 weeks. For long term storage aliquot and freeze at -20 degree C. Storage at 4 degree C may result in protein precipitation. Storage in frost-free freezers is not recommended. This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the protein.; Shelf Life: 12 months from date of despatch

Related Product Information for DENGUE VIRUS TYPE 1 NS1 ANTIGEN recombinant protein

Recombinant dengue virus type 1 NS1 antigen is a purified preparation of the dengue virus serotype 1 (DENV1), non-structural protein 1 (NS1). DENV1 is one of four (DENV1-4) antigenically distinct, closely related viral serotypes belonging to the Flaviviridae family, genus flavivirus. All four serotypes are known to cause viral infection in humans.Dengue virus is common mosquito-borne infection and a major cause of morbidity in tropical and subtropical regions. There is currently no vaccine to prevent, or effective anti-viral drugs to treat, dengue virus infection. In many cases infection is assymptomatic and the majority of individuals who get ill only suffer the mild, non-specific febrile symptoms characteristic of dengue fever (DF). Only a minority of infections result in severe disease, manifesting as dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS). Dengue virus infection gives lifelong immunity to the serotype in question but subsequent infection with another serotype may increase the likelihood of severe disease.The NS1 glycoprotein is essential for viral replication and viability, and since this protein is secreted into the bloodstream, tests have been developed to identify DENV infections using NS1, including antigen-capture ELISA, lateral flow antigen detection, and the measurement of NS1-specific IgM and IgG responses (Guzman, M.G. et al. 2010). Recombinant DENV1 NS1 antigen is presented in its native folded state complete with post-translational modifications, delivering optimal antigenicity and making it suitable for use in vaccine research and serology-based assays.